US2007281972A1PendingUtilityA1

Pharmaceutical Composition Having Prokinetic Effect

36
Assignee: N GENE RES LAB INCPriority: Jun 14, 2004Filed: Jun 13, 2005Published: Dec 6, 2007
Est. expiryJun 14, 2024(expired)· nominal 20-yr term from priority
A61P 1/16A61P 1/04A61P 1/00A61K 31/455A61P 1/18A61P 1/14
36
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention refers to the use of O-(3-piperidino-2-hydroxypropyl)nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof for the preparation of a pharmaceutical composition that restores and/or enhances the activity of the neuronal nitric oxide synthase enzyme.

Claims

exact text as granted — not AI-modified
1 . Use of O-(3-piperidino-2-hydroxypropyl)nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof for the preparation of a pharmaceutical composition that restores and/or enhances the activity of the neuronal nitric oxide synthase enzyme.  
     
     
         2 . The use of  claim 1  for the preparation of a pharmaceutical composition having prokinetic effect.  
     
     
         3 . The use of  claim 2  for the preparation of a pharmaceutical composition for the treatment of the disease reflux esophagitis.  
     
     
         4 . The use of  claim 2  for the preparation of a pharmaceutical composition that enhances the flow of bile from the gall bladder.  
     
     
         5 . The use of  claim 2  for the preparation of a pharmaceutical composition for the treatment of types II and III biliary and pancreatic sorts of sphincter of Oddi dysfunction.  
     
     
         6 . The use of  claim 2  for the preparation of a pharmaceutical composition suitable for the treatment of all types of gastroparesis.  
     
     
         7 . The use of  claim 2  for the preparation of a pharmaceutical composition for the treatment of postcholecystectomy syndrome.  
     
     
         8 . The use of  claim 1  for the preparation of a pharmaceutical composition suitable for the treatment of non-ulcerative colitis.  
     
     
         9 . The use of  claim 1  for the preparation of a pharmaceutical composition suitable for the treatment of defecation disturbances and all types of faecal incontinences.  
     
     
         10 . A method for restoring and/or increasing the activity of the neuronal nitric oxid synthase enzyme in which the patient being in need thereof is treated with a therapeutically effective amount of O-(3-piperidino-2-hydroxypropyl)nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.